Mortality Higher in Myocarditis After Virus Than After COVID

Myocarditis cases following the Pfizer-BioNTech mRNA COVID-19 vaccine are associated with significantly lower mortality than myocarditis linked to viral infection, a registry study suggests.

Related Keywords

Hong Kong , Canada , University Of Hong Kong , Hong Kong General , Ottawa , Ontario , Francisco Tsz Tsun Lai , Peterp Liu , Tahirs Kafil , Pfizer , Clinical Research Network Pcornet , Journal Of The American College Cardiology , Medscape Coronavirus Resource Center , Us National Patient , University Of Ottawa , Coronavirus Resource , Hong Kong Territory , American College , Patient Centered Clinical Research Network , Coronavirus , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc43 , Cov Oc43 , Uman Coronavirus 229e , Cov 229e , Cardiomyopathy , Covid 19 Vaccine , Coronavirus Vaccine , Myocarditis , Pericarditis , Adverse Effects Of Vaccines , Viral Myocarditis , Patient Safety , Vaccine , Viral Illness , Immunizations , Vaccination , Heart Failure , Heart , Cardiac Mri , Ardiac Magnetic R ,